Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 09, 2023

Metastatic Site Patterns by Intrinsic Subtype and HER2DX Risk Scores in Patients With Early-Stage HER2-Positive Breast Cancer

Journal of the National Cancer Institute


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the National Cancer Institute
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer
J. Natl. Cancer Inst 2023 Sep 07;[EPub Ahead of Print], MV Dieci, PP Conte, PG Bisagni, S Bartolini, A Frassoldati, D Generali, F Piacentini, G Griguolo, E Tagliafico, F Brasó Maristany, N Chic, L Paré, F Miglietta, R Vicini, R D'Amico, S Balduzzi, A Prat, V Guarneri

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading